These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27745551)

  • 1. N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial.
    Fraga CM; Tomasi CD; Damasio DC; Vuolo F; Ritter C; Dal-Pizzol F
    Crit Care; 2016 Oct; 20(1):331. PubMed ID: 27745551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: a randomized controlled trial.
    Fraga CM; Tomasi CD; Biff D; Topanotti MF; Felisberto F; Vuolo F; Petronilho F; Dal-Pizzol F; Ritter C
    J Clin Pharmacol; 2012 Sep; 52(9):1365-72. PubMed ID: 22045831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats.
    Petronilho F; Constantino L; de Souza B; Reinke A; Martins MR; Fraga CM; Ritter C; Dal-Pizzol F
    Nephrol Dial Transplant; 2009 Jul; 24(7):2077-82. PubMed ID: 19204016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Ataei S; Hadjibabaie M; Moslehi A; Taghizadeh-Ghehi M; Ashouri A; Amini E; Gholami K; Hayatshahi A; Vaezi M; Ghavamzadeh A
    Hematol Oncol; 2015 Jun; 33(2):67-74. PubMed ID: 24711000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON).
    Komisarof JA; Gilkey GM; Peters DM; Koudelka CW; Meyer MM; Smith SM
    Crit Care Med; 2007 Feb; 35(2):435-41. PubMed ID: 17205018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass.
    Song JW; Shim JK; Soh S; Jang J; Kwak YL
    Nephrology (Carlton); 2015 Feb; 20(2):96-102. PubMed ID: 25384603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
    Adabag AS; Ishani A; Koneswaran S; Johnson DJ; Kelly RF; Ward HB; McFalls EO; Bloomfield HE; Chandrashekhar Y
    Am Heart J; 2008 Jun; 155(6):1143-9. PubMed ID: 18513531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.
    Teixeira KC; Soares FS; Rocha LG; Silveira PC; Silva LA; Valença SS; Dal Pizzol F; Streck EL; Pinho RA
    Pulm Pharmacol Ther; 2008; 21(2):309-16. PubMed ID: 17904883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Acetylcysteine and Desferoxamine Reduce Pulmonary Oxidative Stress Caused by Hemorrhagic Shock in a Porcine Model.
    Mani A; Staikou C; Karmaniolou I; Orfanos N; Mylonas A; Nomikos T; Pafiti A; Papalois A; Arkadopoulos N; Smyrniotis V; Theodoraki K
    J Invest Surg; 2017 Feb; 30(1):33-40. PubMed ID: 27715338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania.
    Valvassori SS; Petronilho FC; Réus GZ; Steckert AV; Oliveira VB; Boeck CR; Kapczinski F; Dal-Pizzol F; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1064-8. PubMed ID: 18403082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and outcome of contrast-associated acute kidney injury assessed with Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) criteria in critically ill patients of medical and surgical intensive care units: a retrospective study.
    Kim MH; Koh SO; Kim EJ; Cho JS; Na SW
    BMC Anesthesiol; 2015; 15():23. PubMed ID: 25780349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation.
    Hilmi IA; Peng Z; Planinsic RM; Damian D; Dai F; Tyurina YY; Kagan VE; Kellum JA
    Nephrol Dial Transplant; 2010 Jul; 25(7):2328-33. PubMed ID: 20179007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial.
    Bove T; Zangrillo A; Guarracino F; Alvaro G; Persi B; Maglioni E; Galdieri N; Comis M; Caramelli F; Pasero DC; Pala G; Renzini M; Conte M; Paternoster G; Martinez B; Pinelli F; Frontini M; Zucchetti MC; Pappalardo F; Amantea B; Camata A; Pisano A; Verdecchia C; Dal Checco E; Cariello C; Faita L; Baldassarri R; Scandroglio AM; Saleh O; Lembo R; Calabrò MG; Bellomo R; Landoni G
    JAMA; 2014 Dec; 312(21):2244-53. PubMed ID: 25265449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.
    Pickkers P; Mehta RL; Murray PT; Joannidis M; Molitoris BA; Kellum JA; Bachler M; Hoste EAJ; Hoiting O; Krell K; Ostermann M; Rozendaal W; Valkonen M; Brealey D; Beishuizen A; Meziani F; Murugan R; de Geus H; Payen D; van den Berg E; Arend J;
    JAMA; 2018 Nov; 320(19):1998-2009. PubMed ID: 30357272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
    Yang C; Bosker FJ; Li J; Schoevers RA
    BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine Plus Deferoxamine Improves Cardiac Function in Wistar Rats After Non-reperfused Acute Myocardial Infarction.
    Phaelante A; Rohde LE; Lopes A; Olsen V; Tobar SA; Cohen C; Martinelli N; Biolo A; Dal-Pizzol F; Clausell N; Andrades M
    J Cardiovasc Transl Res; 2015 Jul; 8(5):328-37. PubMed ID: 26085187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis.
    Ritter C; Andrades ME; Reinke A; Menna-Barreto S; Moreira JC; Dal-Pizzol F
    Crit Care Med; 2004 Feb; 32(2):342-9. PubMed ID: 14758146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
    Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
    Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.